Form D · Pharmaceuticals
SOLAS PHARMA, LLC
Morrisville, NC · CIK 0001522400
Offering snapshot reported Jun 2, 2011 · SEC filing
- Reported sold
- $200K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jun 2, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2011 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-160696
Source: Form D, filed Jun 2, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Bream | Director, Executive |
| Stephen Butts | Director, Executive |
| Moise Khayrallah | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9001 Aerial Center Parkway Suite 110
Morrisville, NC, 27560
Morrisville, NC, 27560